COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD

Ann Rheum Dis. 2020 May;79(5):668-669. doi: 10.1136/annrheumdis-2020-217442. Epub 2020 Apr 2.
No abstract available

Keywords: biological therapy; communicable diseases, imported; cytokines; pulmonary fibrosis; scleroderma, systemic.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Cough / etiology
  • Female
  • Humans
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications*
  • SARS-CoV-2
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab